FinancePrescription Drug Prices Drop to 60-Year Low
U.S. prescription drug prices have fallen at the steepest rate in more than six decades, driven by policy moves like the Most Favored Nation framework and the TrumpRx platform, though real-world savings for consumers depend on insurance design, rebates, and pharmacy costs. Experts caution that CPI measurements differ from actual out-of-pocket costs, attribution of the drop remains contested, and long-term effects are uncertain as gaps with international pricing persist and middlemen like PBMs influence final prices.
